SCHEMBL23035193

SCHEMBL23035193

NC(=O)Nc1ccc(-n2nc(-c3ccccc3)c3c(N)ncnc32)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 8/20 0.70
▸ EGFR P00533 1/20 0.70
▸ AURKA O14965 1/20 0.48
▸ IKBKE Q14164 1/20 0.48
▸ AURKB Q96GD4 1/20 0.48
▸ ABL1 P00519 1/20 0.48
▸ RIPK1 Q13546 1/20 0.45
▸ FYN P06241 2/20 0.44
▸ BTK Q06187 3/20 0.44
▸ LCK P06239 1/20 0.44
▸ CSF1R P07333 1/20 0.44
▸ RET P07949 1/20 0.44
▸ PDGFRB P09619 1/20 0.44
▸ KIT P10721 1/20 0.44
▸ PDGFRA P16234 1/20 0.44
▸ CDK11B P21127 1/20 0.44
▸ CCNC P24863 1/20 0.44
▸ FLT4 P35916 1/20 0.44
▸ FLT3 P36888 1/20 0.44
▸ CDK8 P49336 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2360645 0.83 SRC (1.00) SRCEGFRABL1FYNLCK
SCHEMBL31061171 0.83 SRC (1.00) SRCEGFRABL1FYNLCK
SCHEMBL22364024 0.80 SRC (0.82) SRCEGFRAURKBABL1FYN
SCHEMBL19683595 0.79 FLT3 (0.70) RIPK1BTKLCKCSF1RRET
SCHEMBL14693459 0.77 SRC (0.62) SRCEGFRABL1FYNBTK
SCHEMBL19683865 0.77 SRC (0.52) SRCEGFRAURKAIKBKEAURKB
SCHEMBL13063877 0.75 SRC (0.82) SRCEGFRAURKBABL1FYN
SCHEMBL13019674 0.75 SRC (1.00) SRCEGFRABL1FYNBTK
SCHEMBL19683619 0.73 SRC (0.56) SRCEGFRAURKAIKBKEAURKB
SCHEMBL14693469 0.73 SRC (0.54) SRCEGFRAURKAIKBKEAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3466952-B1 1-(4-(4-AMINO-3-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-1-YL)-PHENYL)-UREA DERIVATIVES AS FLT3 KINASE INHIBITORS FOR TREATING CANCER PRECEDO PHARMACEUTICALS CO LTD (CN) 2021-03-03 — — EP disclosed
Send feedback